Clinical trials: Autoimmune Hemolytic Anemia (AIHA)

Warm Autoimmune Hemolytic Anemia (wAIHA)

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ANX005 in Participants With Warm Autoimmune Hemolytic Anemia (wAIHA)

• Completed
• Age: 18 years and older
• Phase 2
• Results posted

This study will evaluate the safety and tolerability of ANX005 in participants with Warm Autoimmune Hemolytic Anemia (wAIHA).

Trial name

NCT04691570

Testing

ANX005

Where

4 sites in United States, Australia and 2 more

Volunteers

7 people

Sponsor

Annexon, Inc.